These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18361912)

  • 1. [Subacute stent thrombosis in a patient with idiopathic thrombocytopenic purpura treated with intravenous immunoglobulin].
    Hidalgo-Urbano R; Carrascosa-Rosillo C; Martínez-Quesada M; González-Valdayo M
    Rev Esp Cardiol; 2008 Mar; 61(3):329-31. PubMed ID: 18361912
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura.
    Al-Riyami AZ; Lee J; Connolly M; Shereck E
    Pediatr Blood Cancer; 2011 Jul; 57(1):157-9. PubMed ID: 21445949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin or megadose methylprednisolone for the treatment of idiopathic thrombocytopenic purpura.
    Ozsoylu S
    Am J Pediatr Hematol Oncol; 1991; 13(3):364-5. PubMed ID: 1817495
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute immune (idiopathic) thrombocytopenic purpura in childhood.
    Tarantino MD
    Blood Rev; 2002 Mar; 16(1):19-21. PubMed ID: 11913988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intravenous immunoglobulin and high dose anti-D immunoglobulin as initial therapy for childhood immune thrombocytopenic purpura.
    Ozsoylu S
    Br J Haematol; 2011 Mar; 152(6):783-4. PubMed ID: 21275947
    [No Abstract]   [Full Text] [Related]  

  • 7. Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept.
    Litton G
    Am J Hematol; 2008 Apr; 83(4):344. PubMed ID: 18186526
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.
    Rubinstein PG; Chen YH
    Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP).
    Paolini R; Fabris F; Cella G
    Am J Hematol; 2000 Oct; 65(2):177-8. PubMed ID: 10996840
    [No Abstract]   [Full Text] [Related]  

  • 10. Pityriasis lichenoides and idiopathic thrombocytopenic purpura in a young girl.
    Garcia B; Connelly EA; Newbury R; Friedlander SF
    Pediatr Dermatol; 2006; 23(1):21-3. PubMed ID: 16445405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting development of chronic disease in Nordic children with acute onset of idiopathic thrombocytopenic purpura.
    Rosthøj S; Hedlund-Treutiger I; Rajantie J; Zeller B;
    Br J Haematol; 2005 Jul; 130(1):148-9; author reply 150. PubMed ID: 15982360
    [No Abstract]   [Full Text] [Related]  

  • 12. Antenatal intravenous immunoglobulin in chronic immune thrombocytopenic purpura: case report and literature review.
    Howman RA; Barr AL; Shand AW; Dickinson JE
    Fetal Diagn Ther; 2009; 25(1):93-7. PubMed ID: 19218809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with intravenous immunoglobulin is not a panacea but should be limited to those who can benefit.
    Ganly P; Spearing R
    N Z Med J; 2006 Dec; 119(1246):U2335. PubMed ID: 17151709
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose dexamethasone as initial treatment for immune thrombocytopenic purpura.
    Godeau B; Bierling P
    N Engl J Med; 2003 Dec; 349(23):2267-8; author reply 2267-8. PubMed ID: 14657437
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of idiopathic thrombocytopenic purpura in children: the experience of 92 cases].
    Wang YC; Hu LQ; Zhang JS
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):486-8. PubMed ID: 17937865
    [No Abstract]   [Full Text] [Related]  

  • 16. How far should we go with cost-utility analysis when treating children with acute idiopathic thrombocytopenic purpura?
    Benesch M
    Pediatr Blood Cancer; 2008 Feb; 50(2):433. PubMed ID: 17458876
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous IgG for treatment of autoimmune disease.
    Schenkein DP
    Hosp Pract (Off Ed); 1992 Oct; 27(10A):29-36, 39-42 45 passim. PubMed ID: 1400680
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of idiopathic thrombocytopenic purpura in elderly patients.
    Andrès E; Daou S; Zimmer J; Federici L; Maloisel F
    Eur J Haematol; 2007 Feb; 78(2):175. PubMed ID: 17313565
    [No Abstract]   [Full Text] [Related]  

  • 19. Reducing the haemorrhagic risk related to splenectomy in patients with severe chronic idiopathic thrombocytopenic purpura.
    Vianelli N; Gugliotta L; Boschi L; Catani L; Gianni L; Mazzoni M
    Haematologica; 1992; 77(4):371-2. PubMed ID: 1427454
    [No Abstract]   [Full Text] [Related]  

  • 20. Erasmus syndrome associated with an immune thrombocytopenic purpura.
    Fouchard M; Pan Petesch B; Abasq-Thomas C; Saraux A; Misery L; Brenaut E
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e261-e262. PubMed ID: 29314277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.